Article Number of Participants Age (s) Diagnoses Setting Dependent Variable Intervention Implemented Treatment Package or

Article

Number of Participants

Age (s)

Diagnoses

Setting

Dependent Variable

Intervention Implemented

Treatment Package or Independent

Outcome

Albert et al., 2020

Berkley et al., 2020

Carson et al., 2020

Douglas et al., 2020

Measures

Upon meeting inclusion criteria, the articles were then analyzed and quantified across several dimensions: (1) participants, (2) setting, (3) dependent variable, (4) intervention implemented and (5) outcome and generalization.


Participants

Data were collected on the number of participants, age of the participant, and diagnosis. Participants were categorized based on age into four subcategories: 2-3 years old, 4-5 years old, 6-7 years old, 8-9 years old, and 10-12 years old. The participants were also scored based on their stated diagnosis: Autism/Pervasive Developmental Disorder, multiple disabilities, medical disability, sensory impairment, failure to thrive, other disability noted, and/or no disability specified. It was also noted how many participants were included in each of the reviewed studies.

**REPEAT FOR ALL MEASURES- see literature review examples for further examples**

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life

Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa)  Escitalopram (Lexapro)  Fluoxetine (Prozac)  Fluvoxamine (Luvox)  Paroxetine (Paxil)  Sertraline (Zoloft)  SNRIs Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Duloxetine (Cymbalta) Other Mirtazapine (Remeron) Trazadone (Desyrel) Vilazodone (Viibryd) Vortioxetine (Trintellix) Bupropion (Wellbutrin) This

Read below:  Escitalopram  (Lexapro) came on the market once citalopram (Celexa)  lost it patten. Citalopram  (Celexa) also causes mild antagonistic effects a

Read below:  Escitalopram  (Lexapro) came on the market once citalopram (Celexa)  lost it patten. Citalopram  (Celexa) also causes mild antagonistic effects at H1 histamine receptors causing drowsiness which is difficulty to tolerate being a young man.  I will share with you that I never start patients on citalopram. Certainly I have

2/6/24, 9:58 PM SLP – HRM401 Staffing Organizations (2024JAN08FT-1) 1/3 Module 3 – SLP EMPLOYEE SELECTION SLP Assignment For this SLP assignment, review

2/6/24, 9:58 PM SLP – HRM401 Staffing Organizations (2024JAN08FT-1) 1/3 Module 3 – SLP EMPLOYEE SELECTION SLP Assignment For this SLP assignment, review a job decription for a Customer Service Representative position. Then, review the following three resumes of fictitious customer service representatives. Mishka Prakash Lily Wright Michael Williams In

2/6/24, 9:56 PM Case – HRM401 Staffing Organizations (2024JAN08FT-1) 1/7 Module 3 – Case EMPLOYEE SELECTION Assignment Overview Signature Assignment:

2/6/24, 9:56 PM Case – HRM401 Staffing Organizations (2024JAN08FT-1) 1/7 Module 3 – Case EMPLOYEE SELECTION Assignment Overview Signature Assignment: Quantitative Reasoning, Introduced level In this assignment, your quantitative reasoning skills will be assessed. The Quantitative Reasoning rubric will be useful for this purpose. In this course, HRM401, quantitative reasoning

Community Partnerships and Resources Assessment Student Name:_________________________________

Community Partnerships and Resources Assessment Student Name:_________________________________ Date:____________________________ Section I: Utilize this template to guide a short interview with your liaison. Use substantive examples to support each section. Partnership Template Date and Time of Interview Who is your liaison? (Name, title, credentials, etc.) Describe the role they are in currently

Read the following information to answer questions below regarding medication you chose to treat the Primary diagnosis: Major Depressive Disorder, single

Read the following information to answer questions below regarding medication you chose to treat the Primary diagnosis: Major Depressive Disorder, single episode, moderate with anxious distress (F32.1) Objective The client is a 25-year-old, Latino male referred by his primary care provider for a psychiatric evaluation at an outpatient clinic. Client’s